Table.
Experimental Groups | Body Weight, g | Glucose, mmol/L | Insulin, ng/mL | Leptin, ng/mL | PRA, ng AI/mL/h | GFR, mL/min |
---|---|---|---|---|---|---|
SHR (n=5) | ||||||
Control | 329±10† | 6.2±0.3 | 5.3±1.3 | 6.7±3.4 | 5.4±3.4 | 3.8±0.3 |
SHU-9119 | 397±16*† | 6.4±0.4 | 17.4±1.3* | 12.8±3.7* | 9.6±1.2*† | 4.7±0.3*† |
Recovery | 386±10*† | 6.1±0.3 | 4.9±1.0 | 2.2±0.1*† | 9.1±0.8*† | 4.5±0.2* |
WKY (n=5) | ||||||
Control | 462±14 | 6.3±0.2 | 3.8±0.8 | 2.4±0.7 | 5.7±0.8 | 3.8±0.4 |
SHU-9119 | 593±22* | 6.4±0.6 | 15.2±1.3* | 18.8±2.3* | 6.9±0.6 | 6.4±0.6* |
Recovery | 588±28* | 6.4±0.4 | 7.3±2.4 | 12.3±3.1*† | 5.9±0.4 | 4.8±0.3* |
PRA indicates plasma renin activity; GFR, glomerular filtration rate. Values were determined on day 5 of control period, day 11 of SHU-9119 treatment, and day 5 of recovery period.
P<0.05 vs control;
P<0.05 vs WKY.